Newsroom

Company news, product launches and press coverage from EClinCloud.

Article imageNews1 min readQingming Today | Spring Breeze Takes the Brush, All Things RenewAbout EClinCloud: EClinCloud is a leading AI company in the clinical research industry. Driven by AI, it builds an integrated intelligent clinical cloud platform and endpoint assessment technologies, providing global pharmaceutical companies and research institutions with technology products such as eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as scale management, linguistic validation, rater training, and data quality analysis services to build efficient, precise digital solutions. Leveraging AI predictive models and an intelligent data platform, it dynamically assesses and helps improve drug clinical trial success rates, helping shorten drug/device development cycles to benefit patients.640.pngNews2 min readEClinCloud Shares Practical AI Implementation: Empowering All Teams Internally and the Full Platform ExternallyOn March 21, the first 2026 meeting of the Clinical Trial Contract Research Organization Branch (hereinafter referred to as the "CRO Branch") of the China Pharmaceutical Quality Management Association was successfully held in Changsha. Executives from companies including R&G PharmaStudies and Boji Medical, along with nearly 50 representatives from 30 member organizations across the industry, attended the meeting. EClinCloud Shares Practical AI Implementation. Centered on the topic "Company Experiences and Challenges in AI Deployment," the meeting aimed to move the industry from AI literacy to deeper awareness and ultimately to practical application, achieving effective adoption of AI technology across the industry in a pivotal year. As the CRO Branch's thirdArticle imageNews1 min readInternational Women's Day | Every Woman Is a Unique LightEClinCloud wishes every woman a happy Women's Day. Click below to watch the video ↓↓↓ About EClinCloud: EClinCloud is a leading AI company in the clinical research industry, building an AI-driven integrated clinical intelligence cloud platform and endpoint assessment technologies. It provides pharmaceutical companies and research institutions worldwide with technology products such as eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as scale management, linguistic validation, rater training, and data quality analysis services, delivering efficient and precise digital solutions while leveraging AI predictive models and an intelligent data platform to dynamically evaluate and help improve the success rate of drug clinical trials.Article illustrationNews1 min readHappy Lantern Festival: Coming Together in Reunion!EClinCloud wishes everyone a Happy Lantern Festival! About EClinCloud: EClinCloud is a leading AI company in the clinical research industry. Powered by AI, it builds an integrated clinical intelligence cloud platform and endpoint assessment technologies, providing global pharmaceutical companies and research institutions with technology products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, along with scale management, linguistic validation, rater training, and data quality analysis services to build efficient, accurate digital solutions. Relying on AI predictive models and an intelligent data platform, it dynamically assesses and assists in improving drug clinical trial success rates, helping shorten drug/device R&D cycles.Article imageNews1 min readBack to Work! Full Speed Ahead in 2026About EClinCloud: EClinCloud is a leading AI company in the clinical research industry. Driven by AI, it builds an integrated intelligent clinical cloud platform and endpoint assessment technologies, providing global pharmaceutical companies and research institutions with technology products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as scale management, linguistic validation, rater training, and data quality analysis services to build efficient and accurate digital solutions. Leveraging AI predictive models and an intelligent data platform, it dynamically assesses and assists in improving the success rate of drug clinical trials, helping shorten drug and device development cycles and benefiting patients.Article illustrationNews1 min readWelcoming an Auspicious Year of the Horse: EClinCloud Wishes You a Happy Chinese New Year!About EClinCloud: EClinCloud is a leading AI company in the clinical research industry. Powered by AI, it builds an integrated intelligent clinical cloud platform and endpoint assessment technologies, providing global pharmaceutical companies and research institutions with technology products—including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM—as well as scale management, linguistic validation, rater training, and data quality analysis services to build efficient, accurate digital solutions. Relying on AI predictive models and an intelligent data platform, it dynamically assesses and helps improve drug clinical trial success rates, helping shorten drug/device R&D cycles to benefit patients.Article illustrationNews1 min read@Everyone, Please Check Your Annual Memories with EClinCloud!▽Click the video below About EClinCloud EClinCloud is a leading AI company in the clinical research industry. Powered by AI, it builds an integrated intelligent clinical cloud platform and endpoint assessment technologies, providing global pharmaceutical companies and research institutions with technical products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as scale management, linguistic validation, rater training, and data quality analysis services to build efficient and accurate digital solutions. Relying on AI predictive models and an intelligent data platform, it dynamically evaluates and helps improve the success rate of drug clinical trials, helping shorten drug/device R&D cycles to benefit patients.News header image: Congratulations! EClinCloud EDC supports the marketing approval of Core Medical's CorVad interventional left ventricular assist systemNews2 min readCongratulations! EClinCloud EDC Supports Marketing Approval of Core Medical's CorVad Interventional Left Ventricular Assist SystemCongratulations. Recently, Shenzhen Core Medical Technology Co., Ltd. ("Core Medical") announced that China's first interventional left ventricular assist system, the CorVad interventional left ventricular assist device and interventional left ventricular assist catheter pump kit, has officially received NMPA marketing approval. The system uses miniaturized axial motor technology for short-term left ventricular support, marking a domestic first in technology and filling a technical gap in interventional cardiac assist devices in China. This marketing approval of the CorVad interventional left ventricular assist system will lead China's ventricular assist technology toward becoming "minimally invasive and high-efficiency"Gathering Across Mountains and Seas | EClinCloud 2026 Annual Gala Concludes Successfully — Archived article coverNews2 min readGathering Across Mountains and Seas | EClinCloud 2026 Annual Gala Concludes SuccessfullyEClinCloud teams from Ningbo, Shenzhen, Shanghai, Beijing, and Chengdu, including New York, crossed time zones, mountains, and seas to gather in Yibin, the First City on the Yangtze River, for their annual meeting—reflecting on the path traveled and looking ahead to a new journey as a new 2026 beginsCongratulations! EClinCloud eCOA supports approval of Ark Biosciences' new ADHD drug Aizhida® in China — archived article coverNews1 min readCongratulations! EClinCloud eCOA Supports the Approval of ArkBio's New ADHD Drug Aizhida® in ChinaJanuary 6, 2026 — Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") announced that the NMPA has approved the new drug application for serdexmethylphenidate and dexmethylphenidate capsules (Aizhida®) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in patients aged 6 years and those older than 6 years.White Paper | EClinCloud Selected for the 2025 Annual Digital Health Outstanding Innovation Cases — Archived Article CoverNews2 min readWhite Paper | EClinCloud Selected for 2025 Digital Healthcare Annual Innovation Outstanding CasesRecently, VCBeat · VCBeat Research officially released the "2025 Digital Healthcare Annual Innovation White Paper." The white paper systematically reviews industry developments in 2025 across dimensions including policy, industry, products, and capital. Among the featured cases, EClinCloud was selected for the 2025 Digital Healthcare Annual Innovation Outstanding Cases for its digital and AI innovation practices in clinical research, becoming a representative force in the industry.Article imageNews1 min readA New Year Begins: EClinCloud Welcomes 2026 with You!About EClinCloud: EClinCloud is a leading AI company in the clinical research industry, developing an AI-driven integrated intelligent clinical cloud platform and endpoint assessment technologies. It provides global pharmaceutical companies and research institutions with technology products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as scale management, linguistic validation, rater training, and data quality analysis services to build efficient, precise digital solutions. Through AI predictive models and an intelligent data platform, it dynamically assesses and helps improve the success rate of drug clinical trials, helping shorten drug/device R&D cycles to benefit patients.